A Study of OR502, a Monoclonal Antibody Targeting LILRB2, Alone and in Combination With Anticancer Agents

Abroad (travel likely)RecruitingPHASE1, PHASE2

Conditions

Cancer · Tumor, Solid · Malignant Neoplasm · Metastatic Cancer · Advanced Solid Tumor · Cutaneous Melanoma · Non-small Cell Lung Cancer

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

NEXT Austin, Austin, Texas, United States
Contact: Study coordinator (Andrae Vandross, MD) · avandross@nextoncology.com · 737-610-5200
NEXT Dallas, Irving, Texas, United States
Contact: Study coordinator (Shiraj Sen, MD) · ssen@nextoncology.com · 972-893-8800
NEXT Oncology, San Antonio, Texas, United States
Contact: Study coordinator (David Sommerhalder, MD) · dsommerhalder@nextoncology.com · 210-580-9500
NEXT Virginia, Fairfax, Virginia, United States
Contact: Study coordinator (Mohamad A Salkeni, MD) · mohamad.salkeni@usoncology.com · 703-280-9596

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Acupuncture for People Experiencing Period Loss Due to Chemotherapy

Cancer · Period Problem

Abroad (travel likely)RecruitingPHASE2

Basking Ridge, United States · Middletown, United States

Molecular Prediction of Development, Progression or Complications of Kidney, Immune or Transplantation-related Diseases

Acute Kidney Injury · Chronic Kidney Diseases · Solid-organ Transplantation

Abroad (travel likely)Recruiting

Toulouse, France

Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer

Sleep · Fatigue · Anxiety

Abroad (travel likely)RecruitingPHASE2, PHASE3

Houston, United States

ARTEMIS-008：HS-20093 Compared With Topotecan in Subjects With Relapsed Small Cell Lung Cancer

Small Cell Lung Cancer

Abroad (travel likely)RecruitingPHASE3

Beijing, China · Harbin, China